 | Up a level |
Journal Article
Berkessel, A., Ong, M. -C., Nachi, M. and Neudoerfl, J. -M. (2010). Enantiopure Monoprotected cis-1,2-Diaminocyclohexane: One-Step Preparation and Application in Asymmetric Organocatalysis. ChemCatChem, 2 (10). S. 1215 - 1219. MALDEN: WILEY-BLACKWELL. ISSN 1867-3880
Flamme, H., Krallmann, S., Poll-Wolbeck, S. J., Krueger, M., Berkessel, A., Hallek, M. and Kreuzer, K. -A (2014). Novel NO-ASA derivatives are new promising agents in the therapy of chronic lymphocytic leukemia (CLL), other hematologic neoplasia and solid tumors. Oncol. Res. Treat., 37. S. 221 - 222. BASEL: KARGER. ISSN 2296-5262
Flamme, H., Krueger, M., Berkessel, A., Hallek, M. and Kreuzer, K. A. (2015). NOVEL NO-ASA DERIVATIVES ARE NEW PROMISING AGENTS IN THE THERAPY OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND SOLID CANCERS. Haematologica, 100. S. 418 - 419. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078
Flamme, H., Krueger, M., Berkessel, A., Hallek, M. and Kreuzer, K. A. (2015). Novel NO-ASA derivatives are new promising agents in the therapy of chronic lymphocytic leukemia (CLL) and solid cancers. Oncol. Res. Treat., 38. S. 201 - 202. BASEL: KARGER. ISSN 2296-5262
Krallmann, S., Liakos, A., Flamme, H., Poll-Wolbeck, S. J., Krueger, M., Berkessel, A., Hallek, M. and Kreuzer, K-A (2014). Modifications of Nitric Oxide Donating Aspirin (NO-ASA): Enhanced sensitivity and selectivity towards TP53 mutated chronic lymphocytic leukemia (CLL) cells. Oncol. Res. Treat., 37. S. 52 - 53. BASEL: KARGER. ISSN 2296-5262